Alf Bernhardt
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 3
- Hematopoietic Stem Cell Transplantation 2
- Multiple Myeloma Research and Treatments 1
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Rainer R. Haas (5 shared papers)Ulrich Germing (4 shared papers)Manuel A. Aivado (4 shared papers)Barbara Hildebrandt (3 shared papers)Corinna Strupp (2 shared papers)Andrea Kuendgen (2 shared papers)Norbert Gattermann (2 shared papers)Roland R. Fenk (3 shared papers)
- Journals
- Blood (1 paper)Annals of Oncology (1 paper)Cytotherapy (1 paper)Haematologica (1 paper)Bone Marrow Transplantation (1 paper)
- Partner nations
- GermanyTürkiyeUnited States
In The Last Decade
Alf Bernhardt
8 papers receiving 371 citations
Peers
Comparison fields: 5 of 29
- Hematology 213
- Genetics 81
- Molecular Biology 103
- Emergency Medicine 10
- Pathology and Forensic Medicine 10
Countries citing papers authored by Alf Bernhardt
This map shows the geographic impact of Alf Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alf Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alf Bernhardt more than expected).
Fields of papers citing papers by Alf Bernhardt
This network shows the impact of papers produced by Alf Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alf Bernhardt. The network helps show where Alf Bernhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Alf Bernhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 217 | |
| 2 | 2018 | 65 | |
| 3 | Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma. | 2004 | 33 |
| 4 | 2010 | 25 | |
| 5 | 2003 | 23 | |
| 6 | Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study | 2015 | 13 |
| 7 | 2004 | 9 | |
| 8 | combination with all-trans retinoic acid Treatment of myelodysplastic syndromes with valproic acid alone or in | 2013 | 1 |
About Alf Bernhardt
Alf Bernhardt is a scholar working on Hematology, Genetics, Rheumatology, Molecular Biology and Nuclear Energy and Engineering, having authored 8 papers that have together received 386 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Retinoids in leukemia and cellular processes (2 papers), Multiple Myeloma Research and Treatments (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Hematology (213 citations), Genetics (81 citations), Molecular Biology (103 citations), Emergency Medicine (10 citations) and Pathology and Forensic Medicine (10 citations). Alf Bernhardt has collaborated with scholars based in Germany, Türkiye and United States. Frequent co-authors include Rainer R. Haas, Ulrich Germing, Manuel A. Aivado, Barbara Hildebrandt, Corinna Strupp, Andrea Kuendgen, Norbert Gattermann, Roland R. Fenk, Guido Kobbe and Anne‐Sophie Michallet. Their work appears in journals such as Blood, Annals of Oncology, Cytotherapy, Haematologica and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.